EMILY TALKINGTON: Open Payments
NPI 1225543929 · THOMSON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 64 payments from 17 companies in 2025. Trend: 2023 $1,672 · 2024 $1,879 · 2025 $1,008
Food & beverage: $1,008
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $237 |
| ABBVIE INC. | 17 | $172 |
| Janssen Pharmaceuticals, Inc | 5 | $106 |
| Astellas Pharma US Inc | 4 | $76 |
| PFIZER INC. | 4 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $44 |
| Boston Scientific Corporation | 2 | $44 |
| Abbott Laboratories | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
Products named: UBRELVY, Ozempic, SPRAVATO, Wegovy, Veozah, Kerendia, XIFAXAN, FREESTYLE LIBRE 3.
Industry payments across GA — which companies pay providers there.
